Aarti Pharmalabs Limited (AARTIPHARM) — Capital Reinvestment Ratio
Aarti Pharmalabs Limited (AARTIPHARM) has a Capital Reinvestment Ratio of 0.32x as of March 2023, meaning it reinvests 0% of its operating cash flow (Rs1.03 Billion) in capital expenditures (Rs331.54 Million). Check how tangible is Aarti Pharmalabs Limited's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aarti Pharmalabs Limited Capital Reinvestment Ratio (2023–2025)
This chart tracks Aarti Pharmalabs Limited's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Aarti Pharmalabs Limited.
Annual Capital Reinvestment Ratio for Aarti Pharmalabs Limited (2023–2025)
Year-by-year Capital Reinvestment Ratio for Aarti Pharmalabs Limited from 2023 to 2025. See AARTIPHARM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs2.16 Billion | Rs1.99 Billion | ▲ +101.9% |
| 2023 | 0.45x | Rs2.63 Billion | Rs1.20 Billion | — |